Post-Market Surveillance (PMS)
Systematic monitoring of medical device and pharmaceutical performance after market launch.
Key Features
Each capability is delivered by experienced specialists with deep domain expertise.
Adverse Event Reporting
Systematically collecting and analyzing data on adverse events associated with medical products.
Real-World Evidence Collection
Gathering data from real-world use to assess performance, effectiveness, and long-term impact.
Risk Management and Mitigation
Identifying potential risks and implementing strategies to mitigate them.
Data Analysis and Reporting
Employing advanced data analytics to interpret PMS data and identify trends.
Continuous Improvement
Leveraging PMS data to drive continuous improvement in product design and manufacturing.
How We Deliver Post-Market Surveillance (PMS)
Kick-off alignment on objectives, risks, timelines, and required evidence package.
Detailed execution plan with role clarity, communication cadence, and milestone governance.
Delivery with continuous quality checks, documentation control, and corrective action loops.
Readiness close-out with final outputs, handover package, and next-phase roadmap.
Engagement Outcomes
- •Faster preparation and approval cycles with fewer avoidable queries.
- •Higher data and documentation consistency across study milestones.
- •Improved inspection and audit readiness across teams and sites.
- •Clear visibility on risks, decisions, and timeline-critical dependencies.
Other Sub-Services
Explore related capabilities within Safety & Pharmacovigilance.
Ready to Get Started?
Contact our team to learn how Omega CRO can support your clinical research needs.